Response to: Phillips M. et al. “Safety of commercial airflight in patients with brain tumors: a case series”. Journal of Neuro-Oncology (2018) 139:617–623
To the Editor,
We read with great interest the article by Phillips et al.  outlining the overall safety of flying in a population of 41 patients presenting intracranial lesions. The majority of the patients analyzed harbored pituitary tumors or parasellar lesions including skull base meningiomas (80%). The average tumor size was 11.4 cc with maximum dimension of 2.7 cm. A quarter of the evaluated patients (27%) experienced worsening of pre-existing symptoms during flight. Only one patient sustained a grandmal seizure. The authors conclude that patients with intracranial tumors can safely travel via commercial airlines with acceptable risks.
We congratulate the authors’ on a well-written article discussing this important and currently relevant topic. Medical tourism is on the rise and patients are increasingly seeking healthcare away from their home country . Several large healthcare institutions in the US and Europe expand their network globally to export and transfer their work...
- 3.Newmann DG (2006) An analysis of in-flight passenger injuries and medical conditions. Australian Transport Safety Bureau, Canberra City, ISBN: 1 921092 84 XGoogle Scholar
- 4.https://www.emirates.com/media-centre/emirates-sets-standards-for-on-board-medical-care#. February (2017). Accessed 31 Oct 2018